glp-1 weight loss type 1 diabetes Improved Heart and Kidney Outcomes for Patients Taking Drugs | Johns Hopkins How GLP-1 Medications Boost Weight

GIP works synergistically with GLP-1 to enhance insulin secretion and appears to have metabolic effects that support weight loss

These are usually mild and tend to decrease over time as your body gets used to the medication

Ann Pediatr Endocrinol Metab

Mechanisms reported in the literature include: GLP-1 receptor activation Stimulates glucose-dependent insulin release Supports appetite regulation and satiety signaling Slows gastric emptying GIP receptor activation Augments insulin secretion Associated with -cell support and improved nutrient handling Glucagon receptor activation Linked to increased energy expenditure Promotes hepatic lipid mobilization and oxidation Clinical Research Evidence In a published Phase 2 randomized trial, retatrutide produced dose-dependent reductions in body weight, with the highest dose associated with up to approximately 24% mean body-weight reduction at 48 weeks , alongside improvements in cardiometabolic markers

Your healthcare team can advise you on this

In order to be an eligible candidate for either of these medicines, consulting a healthcare professional is highly recommended